Impurity-induced lipid per oxidation and impaired detoxification of aldehydes
by Kerry L. Thomas
The FDA recently defined Fluoroquinolone-Associated Disability (“FQAD”) as a formal review identification for a constellation of symptoms that have been identified in the FDA’s Adverse Event Reporting System (FAERS) in review of data in the fluoroquinolone safety reports.